CD44 and renal cell carcinoma: Andrew Chi et al.42 detected higher CD44 mRNA expression in metastatic RCC tissues than in non-metastatic tissues and that CD44s mRNA expression can be used as an independent prognostic indicator(OR = 1.02, 95%CI 1.01–1.05).